Samsung subsidiary NeuroLogica said it's collaborating with Massachusetts General Hospital (MGH) to pilot the firm's OmniTom Elite scanner with photon-counting detector (PCD) CT technology at the point of care.
The company's OmniTom Elite CT scanner can now be upgraded with photon-counting detector technology, enabling multienergy CT to be utilized in point-of-care imaging applications, according to NeuroLogica. Once U.S. Food and Drug Administration (FDA) 510(k) clearance has been obtained for OmniTom Elite with PCD, MGH will assess the technology for monitoring post-trauma and postsurgical patients in the intensive care unit, NeuroLogica said.
The institution will also guide best practices and evaluate use cases for the system.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
